Stage IIIB Non-Small Cell Lung Cancer
117 clinical trials · Condition
◉ Watch Stage IIIB Non-Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 (NCT00004883) | National Cancer Institute (NCI) | 2000-02-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer (NCT00003869) | National Cancer Institute (NCI) | 1999-04-01 |
Track Stage IIIB Non-Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.